Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Buprenorphine 2 mg/ml Sublingual Drops is a liquid formulation dispensed in a dropper bottle. This design allows for precise and controlled administration by dropping the desired number of drops into the mouth. It is often used for medications requiring smaller doses or for pediatric patients who may have difficulty swallowing tablets or capsules. This medication is used to treat opioid dependence, chronic pain, severe pain, postoperative pain, and cancer pain.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Buprenorphine 2 mg/ml Sublingual Drops is a compounded medication primarily used in the treatment of opioid dependence and chronic pain. This medication is a long-acting opioid agonist that functions by binding to opioid receptors in the brain, thereby reducing cravings and withdrawal symptoms associated with opioid dependence. Additionally, it is utilized in the management of chronic pain due to its long-lasting effect, providing relief for up to 24 hours.
At Bayview Pharmacy, we specialize in the compounding of Buprenorphine 2 mg/ml Sublingual Drops, catering to both patients and prescribers. Our formulation is meticulously designed to ensure a appropriate treatment for opioid dependence and chronic pain. The sublingual drops are dispensed in a dropper bottle, allowing for precise and controlled administration. This form of delivery is particularly beneficial for medications requiring smaller doses and for pediatric patients who may have difficulty swallowing tablets or capsules.
For patients, Buprenorphine 2 mg/ml Sublingual Drops can significantly reduce cravings and withdrawal symptoms associated with opioid dependence. It also offers relief from chronic pain for up to 24 hours. It is crucial to adhere to the instructions provided by your healthcare provider when taking this medication to ensure its effectiveness and your safety.
Our compounded formulation is designed to provide a steady release of the medication over time, making it an ideal choice for long-term treatment plans.
If you have any inquiries about Buprenorphine 2 mg/ml Sublingual Drops or our compounding services, please do not hesitate to contact us at Bayview Pharmacy. We are committed to assisting you in finding the most suitable treatment for your patients.
Buprenorphine 2 mg/ml Sublingual Drops is a liquid formulation specifically designed for the treatment of opioid dependence. This medication is dispensed in a dropper bottle, allowing for precise and controlled administration. The patient can easily administer the required number of drops sublingually, making it a suitable option for those who may struggle with swallowing tablets or capsules.
Buprenorphine is a partial agonist, which means it has a lower potential for abuse and dependence compared to full agonists such as morphine and oxycodone. As a long-acting opioid, buprenorphine can provide sustained relief from opioid withdrawal symptoms for up to 24 hours.
When using Buprenorphine 2 mg/ml Sublingual Drops, it's crucial to be aware of potential drug interactions. This medication may interact with other substances including benzodiazepines, alcohol, and other opioids. Therefore, it's important to inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs, vitamins, and herbal supplements.
Like all medications, Buprenorphine 2 mg/ml Sublingual Drops may cause side effects. Common ones include nausea, vomiting, constipation, dizziness, drowsiness, and headache. If you experience any of these or other side effects, it's important to contact your healthcare provider immediately.
If you have any questions or concerns about Buprenorphine 2 mg/ml Sublingual Drops or any other medication, please don't hesitate to reach out to us at Bayview Pharmacy. We are here to assist you with your medication needs.
Buprenorphine 2 mg/ml Sublingual Drops is a specialized formulation designed to aid in the treatment of opioid dependence and opioid use disorder. This medication functions by binding to opioid receptors in the brain, which helps in reducing cravings and withdrawal symptoms associated with opioid dependence. The unique sublingual drop form allows for the medication to be taken under the tongue, where it is absorbed directly into the bloodstream. This method of administration provides a more rapid onset of action compared to other forms of buprenorphine.
The recommended dosage for this formulation is one drop administered under the tongue every 12 hours. It is important to note that the drops should not be swallowed, as this can significantly reduce the effectiveness of the medication. The sublingual administration allows for the medication to bypass the digestive system and enter the bloodstream directly, ensuring maximum efficacy.
Patients using Buprenorphine 2 mg/ml Sublingual Drops should be closely monitored for signs of opioid withdrawal, as well as for indications of misuse or abuse of the medication. If any of these signs are observed, it may be necessary to adjust the dosage or discontinue the use of the medication. It is crucial to consult with a healthcare provider to ensure the safe and appropriate use of this medication.
Understanding the unique characteristics of this compounded formulation is essential for its proper use and maximum effectiveness. If you have any questions or concerns about Buprenorphine 2 mg/ml Sublingual Drops or its administration, it is recommended to consult with a healthcare provider or pharmacist.
This is a liquid formulation of Buprenorphine, dispensed in a dropper bottle. It is designed for precise and controlled administration by dropping the desired number of drops into the mouth.
This formulation is administered sublingually, which means it is dropped under the tongue. The medication is then absorbed through the mucous membranes in the mouth.
The liquid form allows for smaller doses to be administered more precisely. It is also beneficial for pediatric patients or others who may have difficulty swallowing tablets or capsules.
The dropper bottle is designed for easy use. Simply squeeze the dropper to draw up the medication, then gently release the desired number of drops under the tongue.
No, this medication should be administered directly into the mouth and not mixed with food or drink. This ensures that the correct dose is received.
If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take two doses at the same time.
If you accidentally take more than the recommended dose, seek medical attention immediately. Overdose can cause serious health complications.
No, you should not stop taking this medication abruptly without consulting your healthcare provider. Abrupt discontinuation can lead to withdrawal symptoms.
Side effects can include dizziness, drowsiness, constipation, or headache. If these persist or worsen, contact your healthcare provider immediately.
Consult your healthcare provider before taking this medication if you are pregnant or breastfeeding. Buprenorphine can pass into breast milk and may have undesirable effects on a nursing infant.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take dropper amount orally
